Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-20

Clinical Trial Update: The Effects of Waning of Botulinum Toxin in the Treatment of Cervical Dystonia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update describes a study on the waning of botulinum toxin effectiveness in the treatment of primary cervical dystonia, which is not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Western University, Canada | Conditions: Cervical Dystonia, Primary | Phase 4 | Status: NOT_YET_RECRUITING